DE60127442T2 - Verfahren der pibf-konzentrationsbestimmung zur diagnose eines tumors in einem patienten - Google Patents

Verfahren der pibf-konzentrationsbestimmung zur diagnose eines tumors in einem patienten Download PDF

Info

Publication number
DE60127442T2
DE60127442T2 DE60127442T DE60127442T DE60127442T2 DE 60127442 T2 DE60127442 T2 DE 60127442T2 DE 60127442 T DE60127442 T DE 60127442T DE 60127442 T DE60127442 T DE 60127442T DE 60127442 T2 DE60127442 T2 DE 60127442T2
Authority
DE
Germany
Prior art keywords
pibf
tumor
concentration
fragment
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60127442T
Other languages
German (de)
English (en)
Other versions
DE60127442D1 (de
Inventor
Julia Szekeres-Bartho
Eszter Nagy
Beata Polgar
Tamas Palkovics
Margit Koch
Christoph Klade
Tamas Henics
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Valneva Austria GmbH
Original Assignee
Intercell Austria AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intercell Austria AG filed Critical Intercell Austria AG
Publication of DE60127442D1 publication Critical patent/DE60127442D1/de
Application granted granted Critical
Publication of DE60127442T2 publication Critical patent/DE60127442T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/575—

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60127442T 2000-11-28 2001-11-28 Verfahren der pibf-konzentrationsbestimmung zur diagnose eines tumors in einem patienten Expired - Fee Related DE60127442T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT19972000 2000-11-28
AT0199700A AT410753B (de) 2000-11-28 2000-11-28 Pibf für die diagnose von tumoren
PCT/EP2001/013876 WO2002044734A1 (en) 2000-11-28 2001-11-28 Method for diagnosing a tumor in a patient determining the concentration of pibf

Publications (2)

Publication Number Publication Date
DE60127442D1 DE60127442D1 (de) 2007-05-03
DE60127442T2 true DE60127442T2 (de) 2007-11-29

Family

ID=3689570

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60127442T Expired - Fee Related DE60127442T2 (de) 2000-11-28 2001-11-28 Verfahren der pibf-konzentrationsbestimmung zur diagnose eines tumors in einem patienten

Country Status (9)

Country Link
US (1) US20040142394A1 (enExample)
EP (1) EP1337850B1 (enExample)
JP (2) JP4025645B2 (enExample)
AT (2) AT410753B (enExample)
AU (2) AU2490102A (enExample)
CA (1) CA2431837A1 (enExample)
DE (1) DE60127442T2 (enExample)
ES (1) ES2283461T3 (enExample)
WO (1) WO2002044734A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATA8092002A (de) * 2002-05-28 2005-01-15 Intercell Ag Pibf
JP2015109806A (ja) * 2012-03-22 2015-06-18 アステラス製薬株式会社 新規ｒｅｔ融合体の検出法
GB201702392D0 (en) * 2017-02-14 2017-03-29 Univ Edinburgh Methods for cancer diagnosis using a gene expression signature
CN108447537A (zh) * 2018-03-23 2018-08-24 广西科技大学 一种妊娠期及哺乳期妇女用药安全和健康管理系统
KR102490714B1 (ko) 2018-12-28 2023-01-26 재단법인 아산사회복지재단 Pibf 단백질을 유효성분으로 함유하는 염증성 질환 예방 또는 치료용 약학 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648340A (en) * 1991-10-31 1997-07-15 Barnea; Eytan R. Gestational agents for controlling cell proliferation
US5646003A (en) * 1994-03-23 1997-07-08 Barnea; Eytan R. Preimplantation factor
WO1999014372A1 (en) * 1997-09-15 1999-03-25 Abbott Laboratories Reagents and methods useful for detecting diseases of the urinary tract
AU4728299A (en) * 1998-07-02 2000-01-24 Envision Biomedical Consulting Antiproliferative and antiviral proteins and peptides
WO2001027633A1 (en) * 1999-10-08 2001-04-19 Envision Biomedical Consulting Gestational agents which modulate cell proliferation

Also Published As

Publication number Publication date
ES2283461T3 (es) 2007-11-01
US20040142394A1 (en) 2004-07-22
AT410753B (de) 2003-07-25
AU2490102A (en) 2002-06-11
ATA19972000A (de) 2002-12-15
ATE357662T1 (de) 2007-04-15
DE60127442D1 (de) 2007-05-03
AU2002224901B2 (en) 2006-11-09
JP2006230407A (ja) 2006-09-07
JP2004514909A (ja) 2004-05-20
EP1337850A1 (en) 2003-08-27
EP1337850B1 (en) 2007-03-21
WO2002044734A1 (en) 2002-06-06
JP4025645B2 (ja) 2007-12-26
CA2431837A1 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
DE69334071T2 (de) Prostata-spezifisches membranantigen
DE69833014T2 (de) Menschliche toll homologen
DE60118382T2 (de) Protoonkogen aus menschlichem Zervikalkarzinom 2 und darin kodiertes Protein
DE69735375T2 (de) Genfamilie von apoptose-verwandten peptiden, dadurch kodierte peptide und verfahren zu deren herstellung
DE60121346T2 (de) Suppressor-Gen
Eitner et al. Role of interleukin-6 in mediating mesangial cell proliferation and matrix production in vivo
DE69932510T2 (de) Vaskularisierungsinhibitoren
EP2314610B1 (de) Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
EP2327721B1 (de) Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
DE69722035T2 (de) Neue testmethode, um den differenzierungszustand von bauchspeicheldrüsenzellen eines säugetieres festzustellen.
DE69126038T2 (de) Diagnose von krebs-metastasen durch das mts-1 gen
DE60210297T2 (de) Verwendung von langem pentraxin ptx3 für die behandlung von infertilität bei frauen
DE60127442T2 (de) Verfahren der pibf-konzentrationsbestimmung zur diagnose eines tumors in einem patienten
WO2001002556A2 (de) Mittel zur diagnose, prognose und therapie maligner erkrankungen
DE9219038U1 (de) Immunotestsystem für lösliches lymphoides CD30-Antigen
Iborra et al. Expression of complement regulatory proteins [membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59)] in endometrial stressed cells
EP3258272B1 (en) Screening method for pain-relieving substances, and pharmaceutical composition for prevention or treatment of pain
DE69733491T2 (de) In Krebszellen überexprimiertes Genprodukt
WO2003100428A2 (de) Verfahren zu diagnostizierung eines tumors bei einem patienten durch bestimmung von pibf
DE69737570T2 (de) Agentien zur präsymptomatischen Detektion, Prävention und Behandlung von Brustkrebs in Menschen
EP1386615B1 (de) EG-VEGF/Prokineticin 2 Rezeptor Antagonisten
EP1646649B1 (de) Macc1-polypeptid und dessen verwendung für die tumordiagnostik und tumortherapie
AU2002224901A1 (en) Method for diagnosing a tumor in a patient determining the concentration of PIBF
DE69533804T2 (de) Mimetika von aus alternden Zellen abgeleiteten Hemmern der DNA-Synthese
DE60319693T2 (de) Marker fur lungentumoren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee